Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma-Reference-Cited by-同舟云学术

Targeting transferrin receptors at the blood-brain barrier improves the uptake of immunoliposomes and subsequent cargo transport into the brain parenchyma

Published:2017-09-04 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Johnsen Kasper Bendix,Burkhart Annette,Melander Fredrik,Kempen Paul Joseph^ORCID,Vejlebo Jonas Bruun,Siupka Piotr,Nielsen Morten Schallburg,Andresen Thomas Lars,Moos Torben

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-11220-1.pdf

Reference46 articles.

1. Abbott, N. J. Blood-brain barrier structure and function and the challenges for CNS drug delivery. J. Inherit. Metab. Dis. 36, 437–449 (2013).

2. Zlokovic, B. V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178–201 (2008).

3. Saraiva, C. et al. Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. J Control Release 235, 34–47 (2016).

4. Johnsen, K. B. & Moos, T. Revisiting nanoparticle technology for blood-brain barrier transport: Unfolding at the endothelial gate improves the fate of transferrin receptor-targeted liposomes. J Control Release 222, 32–46 (2016).

5. Leitner, D. F. & Connor, J. R. Functional roles of transferrin in the brain. Biochim. Biophys. Acta 1820, 393–402 (2012).

Cited by 196 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retinoic acid in Parkinson's disease: Molecular insights, therapeutic advances, and future prospects;Life Sciences;2024-10

2. Lactoferrin/CD133 antibody conjugated nanostructured lipid carriers for dual targeting of blood–brain-barrier and glioblastoma stem cells;Biomedical Materials;2024-08-22

3. A Human Brain-Chip for modelling brain pathologies and screening of BBB crossing therapeutic strategies;2024-08-12

4. Matrix Protein of Vesicular Stomatitis Virus Targets the Mitochondria, Reprograms Glucose Metabolism, and Sensitizes to 2-Deoxyglucose in Glioblastoma;Human Gene Therapy;2024-08-02

5. Nanotechnology-based Drug Delivery for Alzheimer's and Parkinson's Diseases;Current Drug Delivery;2024-08